Share chart Bausch + Lomb Corporation
Extended chart
Simple chart
About Bausch + Lomb Corporation
Bausch + Lomb Corporation работает как компания по охране здоровья глаз в Канаде и за рубежом. Он работает в трех сегментах: Vision Care / Consumer Health Care, Ophthalmic Pharmaceuticals и Surgical. more detailsIPO date | 2022-05-06 |
---|---|
ISIN | CA0717051076 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.bausch.com |
Цена ао | 15.67 |
Change price per day: | 0% (15.67) |
---|---|
Change price per week: | -0.5079% (15.75) |
Change price per month: | -1.88% (15.97) |
Change price per 3 month: | -13.62% (18.14) |
Change price per half year: | -17.31% (18.95) |
Change price per year: | -8.95% (17.21) |
Change price per year to date: | -13.23% (18.06) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
FIL LTD | 8114995 | 2.31 |
Goldentree Asset Management LP | 4715829 | 1.34 |
Maple Rock Capital Partners, Inc. | 3745062 | 1.07 |
ICAHN CARL C | 3500000 | 1 |
Citadel Advisors Llc | 2546302 | 0.73 |
River Road Asset Management, LLC | 1938207 | 0.55 |
Freshford Capital Management, LLC | 1754123 | 0.5 |
Alberta Investment Management Corp | 1351793 | 0.39 |
Nomura Holdings Inc. | 1256181 | 0.36 |
Laurion Capital Management, LP | 1033880 | 0.29 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Ballast Small/Mid Cap ETF | 2.17545 | 22.43 | 1.50952 |
Invesco Zacks Mid-Cap ETF | 0.47351 | 27.94 | 1.99956 |
Renaissance IPO ETF | 0.34056 | 35.75 | 0.35581 |
BNY Mellon US Small Cap Core Equity ETF | 0.03413 | 30.07 | 1.75333 |
Schwab Fundamental International Small Co. Index ETF | 0.00704 | 8.31 | 3.46652 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.00253 | 13.06 | 3.62488 |
Goldman Sachs MarketBeta U.S. 1000 Equity ETF | 0.00146 | 33 | 1.42661 |
Dimensional International Core Equity 2 ETF | 0.00132 | 6.52 | 3.69996 |
0.38 | 22.14 | 2.23 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Osama A. Eldessouky | Executive VP & CFO | 1.09M | 1972 (53 years) |
Dr. Yehia Hashad M.D. | Executive VP of Research & Development and Chief Medical officer | 1.09M | 1968 (57 years) |
Mr. Brenton L. Saunders J.D. | CEO & Chairman | N/A | 1970 (55 years) |
Mr. Frederick J. Munsch | Senior VP, Controller & Chief Accounting Officer | N/A | 1971 (54 years) |
Mr. A. Robert D. Bailey | Executive VP & Chief Legal Officer | N/A | 1963 (62 years) |
Mr. Alan Waterhouse CPFA, MBA | Executive VP and Chief Supply Chain & Operations Officer | N/A | 1960 (65 years) |
Mr. Jonathon L. Kellerman | Chief Compliance Officer | N/A | |
T.J. Crawford | Chief Communications Officer | N/A | |
Dr. Manisha A. Narasimhan Ph.D. | Chief Corporate Development & Digital Officer | N/A | 1977 (48 years) |
Mr. Andrew Stewart | President of Global Pharmaceuticals & International Consumer | 1975 (50 years) |
Address: Canada, Vaughan. ON LK B, 520 Applewood Crescent - open in Google maps, open in Yandex maps
Website: https://www.bausch.com
Website: https://www.bausch.com